Combination Cancer Therapy : Modulators and Potentiators (Cancer Drug Discovery and Development) (2005)

234.98 AUD
Member Price
211.49
English

Product Description

The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer.

Available to Order

Usually dispatches within 3-4 weeks

While every attempt has been made to ensure stock availability, occasionally we may run out of stock at our stores.

Free domestic shipping on orders over 99.00AUD

Discount is applied at checkout.

Recently Viewed Items

Related Products